Rami A Al-Horani

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 39

Top Venues

Medicinal chemistry (Shariqah (United Arab Emirates))

ACS omega

Pharmaceutical patent analyst

Current diabetes reviews

Xavier University of Louisiana

Virginia Commonwealth University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Xavier University of Louisiana

United States

Associate Professor :: Division of Pharmaceutical Sciences

Xavier University of Louisiana

United States

Assistant Professor :: Division of Pharmaceutical Sciences

Virginia Commonwealth University

United States

Senior Research Scientist and Postdoctoral Fellow :: Department of Medicinal Chemistry & Institute for Structural Biology, Drug Discovery and Development

Education History

Virginia Commonwealth University

United States

PHD :: Medicinal Chemistry

University of Jordan

Jordan

MSC :: Pharmaceutical Sciences

Publications

Rami A Al-Horani, Kholoud F Aliter, Hashem F Aliter
Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity. Current diabetes reviews 20 (8) (2024)
Rami A Al-Horani, Kholoud F Aliter
Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic. Medicinal chemistry (Shariqah (United Arab Emirates)) 20 (4) (2024)
Kayla T Vu, Srabani Kar, Navneet Goyal, Madhusoodanan Mottamal, Daniel K Afosah, Rami A Al-Horani
Discovery of Heparin Mimetic, Potent, and Selective Inhibitors of Human Clotting Factor XIIIa. ACS omega 9 (28) (2024)
Rami A Al-Horani, Kholoud F Aliter
Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic. Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
Ma'Lik D Woodland, Anthony Thompson, Amanda Lipford, Navneet Goyal, John C Schexnaildre, Madhusoodanan Mottamal, Daniel K Afosah, Rami A Al-Horani
New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants. ACS omega 9 (9) (2024)
Rami A Al-Horani, Kholoud F Aliter
Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic. Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
Kayla T Vu, Srabani Kar, Navneet Goyal, Madhusoodanan Mottamal, Daniel K Afosah, Rami A Al-Horani
Discovery of Heparin Mimetic, Potent, and Selective Inhibitors of Human Clotting Factor XIIIa. ACS omega 9 (28) (2024)
Rami A Al-Horani, Kholoud F Aliter
Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic. Medicinal chemistry (Shariqah (United Arab Emirates)) 20 (4) (2024)
Ma'Lik D Woodland, Anthony Thompson, Amanda Lipford, Navneet Goyal, John C Schexnaildre, Madhusoodanan Mottamal, Daniel K Afosah, Rami A Al-Horani
New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants. ACS omega 9 (9) (2024)
Rami A Al-Horani, Kholoud F Aliter, Hashem F Aliter
Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity. Current diabetes reviews (2024)
Rami A Al-Horani, Kholoud F Aliter
Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic. Medicinal chemistry (Shariqah (United Arab Emirates)) 20 (4) (2024)
Rami A Al-Horani, Kholoud F Aliter, Hashem F Aliter
Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity. Current diabetes reviews (2024)
Ma'Lik D Woodland, Anthony Thompson, Amanda Lipford, Navneet Goyal, John C Schexnaildre, Madhusoodanan Mottamal, Daniel K Afosah, Rami A Al-Horani
New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants. ACS omega 9 (9) (2024)
Rami A Al-Horani, Kholoud F Aliter
Triple Action of Lignosulfonic Acid Sodium: Anti-protease, Antioxidant, and Anti-inflammatory Effects of a Polymeric Heparin Mimetic. Medicinal chemistry (Shariqah (United Arab Emirates)) 20 (4) (2024)
Rami A Al-Horani
Riluzole and its prodrugs for the treatment of Alzheimer's disease. Pharmaceutical patent analyst (2023)
Aaryana Jones, Rami A Al-Horani
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors. Medical sciences (Basel, Switzerland) 11 (3) (2023)
Ahlam Ayyad, Rami A Al-Horani
Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile. Gastroenterology insights 14 (4) (2023)
Daniel K Afosah, Rawan M Fayyad, Valerie R Puliafico, Spencer Merrell, Eltice K Langmia, Sophie R Diagne, Rami A Al-Horani, Umesh R Desai
Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G. Biomolecules 13 (5) (2023)
Rami A Al-Horani, Daniel K Afosah, Srabani Kar, Kholoud F Aliter, Madhusoodanan Mottamal
Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G. RPS pharmacy and pharmacology reports 2 (1) (2023)
Rami A Al-Horani, Daniel K Afosah, Srabani Kar, Kholoud F Aliter, Madhusoodanan Mottamal
Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G. RPS pharmacy and pharmacology reports 2 (1) (2023)
Rami A Al-Horani
Steroid sulfatase inhibitors and sulfated C19 steroids for proteotoxicity-related diseases: a patent spotlight. Pharmaceutical patent analyst (2023)
Rami A Al-Horani
4-(Imidazo[1,2-a]pyridin-3-yl): pyrimidine derivatives as anticancer agents. Pharmaceutical patent analyst (2022)
Raquel Chiles, Rami A Al-Horani
Vericiguat: A New Hope for Heart Failure Patients. Cardiovascular therapeutics 2022 (2022)
Daniel K Afosah, Edward Ofori, Madhusoodanan Mottamal, Rami A Al-Horani
Factor IX(a) inhibitors: an updated patent review (2003-present). Expert opinion on therapeutic patents 32 (4) (2022)
Rami A Al-Horani, Raquel Chiles
First Therapeutic Approval for Eosinophilic Esophagitis. Gastroenterology insights 13 (3) (2022)
Raquel Chiles, Rami A Al-Horani
Vericiguat: A New Hope for Heart Failure Patients. Cardiovascular therapeutics 2022 (2022)
Srabani Kar, Page Bankston, Daniel K Afosah, Rami A Al-Horani
Lignosulfonic Acid Sodium Is a Noncompetitive Inhibitor of Human Factor XIa. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Rami A Al-Horani, Kholoud F Aliter, Srabani Kar, Madhusoodanan Mottamal
Sulfonated Nonsaccharide Heparin Mimetics Are Potent and Noncompetitive Inhibitors of Human Neutrophil Elastase. ACS omega 6 (19) (2021)
Rami A Al-Horani
Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections. American journal of cardiovascular drugs : drugs, devices, and other interventions 20 (6) (2020)
Rami A Al-Horani, Srabani Kar
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review. Viruses 12 (10) (2020)
Rami A Al-Horani, Srabani Kar, Kholoud F Aliter
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials. International journal of molecular sciences 21 (15) (2020)
Rami A Al-Horani
Targeting factor XI(a) for anticoagulation therapy: a patent landscape. Pharmaceutical patent analyst 9 (1) (2020)
Kholoud F Aliter, Rami A Al-Horani
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19. Cardiovascular drugs and therapy 35 (2) (2020)
Srabani Kar, Madhusoodanan Mottamal, Rami A Al-Horani
Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia. ChemistryOpen 9 (11) (2020)
Rami A Al-Horani
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present). Expert opinion on therapeutic patents 30 (1) (2019)
Rami A Al-Horani, Daytriona Clemons, Madhusoodanan Mottamal
The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis. Molecules (Basel, Switzerland) 24 (11) (2019)
Rami A Al-Horani, Elsamani I Abdelfadiel, Daniel K Afosah, Shravan Morla, Jyothi C Sistla, Bassem Mohammed, Erika J Martin, Masahiro Sakagami, Donald F Brophy, Umesh R Desai
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding. Journal of thrombosis and haemostasis : JTH 17 (12) (2019)
Page Clemons Bankston, Rami A Al-Horani
New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations. International journal of molecular sciences 20 (12) (2019)
Rami A Al-Horani, Daniel K Afosah
Recent advances in the discovery and development of factor XI/XIa inhibitors. Medicinal research reviews 38 (6) (2018)

Rami A Al-Horani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rami A Al-Horani